| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6046934
[patent_doc_number] => 20020168393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Implantable medical material and implantable medical device'
[patent_app_type] => new
[patent_app_number] => 10/136364
[patent_app_country] => US
[patent_app_date] => 2002-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5461
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168393.pdf
[firstpage_image] =>[orig_patent_app_number] => 10136364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/136364 | Implantable medical material and implantable medical device | May 1, 2002 | Abandoned |
Array
(
[id] => 6724628
[patent_doc_number] => 20030206940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Personal care article with distinct active zone'
[patent_app_type] => new
[patent_app_number] => 10/134207
[patent_app_country] => US
[patent_app_date] => 2002-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13349
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20030206940.pdf
[firstpage_image] =>[orig_patent_app_number] => 10134207
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/134207 | Personal care article with distinct active zone | Apr 25, 2002 | Issued |
Array
(
[id] => 6787293
[patent_doc_number] => 20030138532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Food and beverage preservative'
[patent_app_type] => new
[patent_app_number] => 10/132019
[patent_app_country] => US
[patent_app_date] => 2002-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1394
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10132019
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/132019 | Food and beverage preservative | Apr 23, 2002 | Abandoned |
Array
(
[id] => 6806990
[patent_doc_number] => 20030196929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Pharmaceutical kit for migraine headache treatment'
[patent_app_type] => new
[patent_app_number] => 10/125821
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3114
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20030196929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10125821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/125821 | Pharmaceutical kit for migraine headache treatment | Apr 18, 2002 | Abandoned |
Array
(
[id] => 6874151
[patent_doc_number] => 20030194448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Oral rehydration composition'
[patent_app_type] => new
[patent_app_number] => 10/125367
[patent_app_country] => US
[patent_app_date] => 2002-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3615
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20030194448.pdf
[firstpage_image] =>[orig_patent_app_number] => 10125367
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/125367 | Oral rehydration composition | Apr 15, 2002 | Abandoned |
Array
(
[id] => 637379
[patent_doc_number] => 07125563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-24
[patent_title] => 'Sustained release pharmaceutical preparations and methods for producing the same'
[patent_app_type] => utility
[patent_app_number] => 10/120501
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11280
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/125/07125563.pdf
[firstpage_image] =>[orig_patent_app_number] => 10120501
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/120501 | Sustained release pharmaceutical preparations and methods for producing the same | Apr 11, 2002 | Issued |
Array
(
[id] => 6805493
[patent_doc_number] => 20030232887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Preparation and use of a stable formulation of allosteric effector compounds'
[patent_app_type] => new
[patent_app_number] => 10/120848
[patent_app_country] => US
[patent_app_date] => 2002-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7644
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232887.pdf
[firstpage_image] =>[orig_patent_app_number] => 10120848
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/120848 | Preparation and use of a stable formulation of allosteric effector compounds | Apr 9, 2002 | Abandoned |
| 09/980775 | Lamivudine containing pharmaceutical formulation | Apr 8, 2002 | Abandoned |
Array
(
[id] => 6652105
[patent_doc_number] => 20030105144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Stabilized oral pharmaceutical composition'
[patent_app_type] => new
[patent_app_number] => 10/119118
[patent_app_country] => US
[patent_app_date] => 2002-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18236
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105144.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119118 | Stabilized oral pharmaceutical composition | Apr 8, 2002 | Abandoned |
| 09/980360 | Modified biodegradable polyester microspheres for stabilizing and improving the release profile of drugs encapsulated within the microspheres | Apr 7, 2002 | Abandoned |
Array
(
[id] => 6729694
[patent_doc_number] => 20030185884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine'
[patent_app_type] => new
[patent_app_number] => 10/113088
[patent_app_country] => US
[patent_app_date] => 2002-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10647
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20030185884.pdf
[firstpage_image] =>[orig_patent_app_number] => 10113088
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/113088 | Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine | Mar 31, 2002 | Abandoned |
Array
(
[id] => 6729697
[patent_doc_number] => 20030185887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Controlled release oral dosage form of beta-adrenergic blocking agents'
[patent_app_type] => new
[patent_app_number] => 10/109408
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5210
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20030185887.pdf
[firstpage_image] =>[orig_patent_app_number] => 10109408
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/109408 | Controlled release oral dosage form of beta-adrenergic blocking agents | Mar 27, 2002 | Issued |
Array
(
[id] => 644771
[patent_doc_number] => 07118764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-10
[patent_title] => 'Process for cooking/drying high-amylose starches'
[patent_app_type] => utility
[patent_app_number] => 10/105661
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2784
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/118/07118764.pdf
[firstpage_image] =>[orig_patent_app_number] => 10105661
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/105661 | Process for cooking/drying high-amylose starches | Mar 24, 2002 | Issued |
| 10/088875 | RETARD FORM CONTAINING ALPHA-LIPOIC ACID (DERIVATIVES) | Mar 19, 2002 | Abandoned |
Array
(
[id] => 6441786
[patent_doc_number] => 20020176841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Pharmaceutical formulations for sustained release'
[patent_app_type] => new
[patent_app_number] => 10/102530
[patent_app_country] => US
[patent_app_date] => 2002-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6685
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20020176841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10102530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/102530 | Pharmaceutical formulations for sustained release | Mar 18, 2002 | Abandoned |
| 10/009583 | Pigment | Mar 18, 2002 | Abandoned |
Array
(
[id] => 982062
[patent_doc_number] => 06926906
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-09
[patent_title] => 'Orally administrable pharmaceutical formulation'
[patent_app_type] => utility
[patent_app_number] => 10/096564
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1696
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/926/06926906.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096564
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096564 | Orally administrable pharmaceutical formulation | Mar 12, 2002 | Issued |
Array
(
[id] => 6740896
[patent_doc_number] => 20030158265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Orally administrable pharmaceutical formulation comprising pseudoephedrine hydrochloride and process for preparing the same'
[patent_app_type] => new
[patent_app_number] => 10/096709
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1779
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158265.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096709
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096709 | Orally administrable pharmaceutical formulation comprising pseudoephedrine hydrochloride and process for preparing the same | Mar 12, 2002 | Abandoned |
Array
(
[id] => 6740895
[patent_doc_number] => 20030158264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same'
[patent_app_type] => new
[patent_app_number] => 10/096708
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1646
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158264.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096708 | Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same | Mar 12, 2002 | Abandoned |
Array
(
[id] => 6463050
[patent_doc_number] => 20020150632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Psychonutracological method for craving reduction in humans'
[patent_app_type] => new
[patent_app_number] => 10/095216
[patent_app_country] => US
[patent_app_date] => 2002-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3527
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20020150632.pdf
[firstpage_image] =>[orig_patent_app_number] => 10095216
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/095216 | Psychonutracological method for craving reduction in humans | Mar 11, 2002 | Abandoned |